Literature DB >> 22424127

A systematic review of behavioural changes in motor neuron disease.

Joost Raaphorst1, Emma Beeldman, Marianne De Visser, Rob J De Haan, Ben Schmand.   

Abstract

Motor neuron disease (MND) and the behavioural variant of frontotemporal dementia (bvFTD) are thought to be part of a disease spectrum. There is uncertainty about the frequency and characteristics of behavioural changes in MND, and similarly, about a relation between bvFTD and the site of onset of MND. Our aim was to perform a systematic review of the publications on behavioural changes in MND. An extensive search for articles on behavioural changes in MND patients was performed. First, cohort studies of MND patients were reviewed to summarize the prevalence of bvFTD and mild behavioural changes. Secondly, data on bvFTD symptoms (mostly from case reports) of individual MND-bvFTD patients were used to analyse characteristics and pooled prevalences of bvFTD symptoms. In addition, site of onset, survival and demographic variables of MND-bvFTD patients were analysed. Results showed that in cohorts, 8.1% (95% CI 5.6 - 11.5%) of MND patients had bvFTD. In 170 individual patients with MND-bvFTD, perseveration (40%), apathy (29%) and disinhibition (26%) were the most frequently reported behavioural changes; 43% had memory disturbances and bulbar onset was found in 48%. In conclusion, 8% of MND patients have bvFTD, with perseveration being reported most frequently. MND-bvFTD is often accompanied by memory disturbances and is related to bulbar onset.

Entities:  

Mesh:

Year:  2012        PMID: 22424127     DOI: 10.3109/17482968.2012.656652

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  19 in total

1.  Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.

Authors:  Stella A Glasmacher; Charis Wong; Iona E Pearson; Suvankar Pal
Journal:  JAMA Neurol       Date:  2020-03-01       Impact factor: 18.302

2.  ALS-Plus syndrome: non-pyramidal features in a large ALS cohort.

Authors:  Leo McCluskey; Shannon Vandriel; Lauren Elman; Vivianna M Van Deerlin; John Powers; Ashley Boller; Elisabeth McCarty Wood; John Woo; Corey T McMillan; Katya Rascovsky; Murray Grossman
Journal:  J Neurol Sci       Date:  2014-07-18       Impact factor: 3.181

3.  Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China.

Authors:  QianQian Wei; XuePing Chen; ZhenZhen Zheng; Rui Huang; XiaoYan Guo; Bei Cao; Bi Zhao; Hui-Fang Shang
Journal:  J Neurol       Date:  2014-09-24       Impact factor: 4.849

Review 4.  Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Colin J Mahoney; Rebekah M Ahmed; William Huynh; Sicong Tu; Jonathan D Rohrer; Richard S Bedlack; Orla Hardiman; Matthew C Kiernan
Journal:  CNS Drugs       Date:  2021-05-15       Impact factor: 5.749

Review 5.  Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?

Authors:  Fabiola De Marchi; Claudia Carrarini; Antonio De Martino; Luca Diamanti; Antonio Fasano; Antonino Lupica; Mirella Russo; Simone Salemme; Edoardo Gioele Spinelli; Alessandro Bombaci
Journal:  Neurol Sci       Date:  2021-03-27       Impact factor: 3.307

6.  Regional prefrontal cortical atrophy predicts specific cognitive-behavioral symptoms in ALS-FTD.

Authors:  Elena Ratti; Kimiko Domoto-Reilly; Christina Caso; Alyssa Murphy; Michael Brickhouse; Daisy Hochberg; Nikos Makris; Merit E Cudkowicz; Bradford C Dickerson
Journal:  Brain Imaging Behav       Date:  2021-02-15       Impact factor: 3.224

Review 7.  Patients experiences of maintaining mental well-being and hope within motor neuron disease: a thematic synthesis.

Authors:  Andrew Soundy; Nicola Condon
Journal:  Front Psychol       Date:  2015-05-12

8.  Case Report: Cognitive Conversion in a Non-brazilian VAPB Mutation Carrier (ALS8).

Authors:  Anna G M Temp; Martin Dyrba; Elisabeth Kasper; Stefan Teipel; Johannes Prudlo
Journal:  Front Neurol       Date:  2021-06-02       Impact factor: 4.003

9.  What are the roles of carers in decision-making for amyotrophic lateral sclerosis multidisciplinary care?

Authors:  Anne Hogden; David Greenfield; Peter Nugus; Matthew C Kiernan
Journal:  Patient Prefer Adherence       Date:  2013-02-28       Impact factor: 2.711

10.  Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.

Authors:  Seong-il Oh; Aram Park; Hee-Jin Kim; Ki-Wook Oh; Hojin Choi; Min-Jung Kwon; Chang-Seok Ki; Hee-Tae Kim; Seung Hyun Kim
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.